DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy

Pfaar, Oliver; Hamelmann, Eckard; Taube, Christian; Wagenmann, Martin; Wedi, Bettina; Werfel, Thomas; Bartel, Detlef; Bonertz, Andreas; Hartenstein, Diana; Kaul, Susanne; Mahler, Vera; Worm, Margitta

DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy

Pfaar O, Hamelmann E, Taube C, Wagenmann M, Wedi B, Werfel T, Bartel D, Bonertz A, Hartenstein D, Kaul S, Mahler V, et al. (2023)
Allergologie Select 7(1): 229-235.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!

DOI

https://doi.org/10.5414/ALX02450E

Autor*in

Pfaar, Oliver; Hamelmann, Eckard^UniBi; Taube, Christian; Wagenmann, Martin; Wedi, Bettina; Werfel, Thomas; Bartel, Detlef; Bonertz, Andreas; Hartenstein, Diana; Kaul, Susanne; Mahler, Vera; Worm, Margitta

Einrichtung

Medizinische Fakultät OWL > AG 102 Kinderheilkunde

Abstract / Bemerkung

A roundtable discussion on February 10, 2023 between the German Society for Allergology and Clinical Immunology (DGAKI) and the Paul-Ehrlich-Institut (PEI) aimed to discuss in detail current aspects of allergen immunotherapy (AIT), its regulatory framework under the transitional provision of the Therapy Allergen Ordinance (TAO), and the consequences for the planned guideline work of the DGAKI, regulatory challenges in the approval of AIT products for children and adolescents as well as allergy diagnostics. The content and discussion points of this dialogue are summarized and are set in context with the current literature. © Dustri-Verlag Dr. K. Feistle.

Erscheinungsjahr

2023

Zeitschriftentitel

Allergologie Select

Band

Ausgabe

Seite(n)

229 - 235

eISSN

2512-8957

Page URI

https://pub.uni-bielefeld.de/record/2985600

Zitieren

Pfaar O, Hamelmann E, Taube C, et al. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select. 2023;7(1):229-235.

Pfaar, O., Hamelmann, E., Taube, C., Wagenmann, M., Wedi, B., Werfel, T., Bartel, D., et al. (2023). DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select, 7(1), 229-235. https://doi.org/10.5414/ALX02450E

Pfaar, Oliver, Hamelmann, Eckard, Taube, Christian, Wagenmann, Martin, Wedi, Bettina, Werfel, Thomas, Bartel, Detlef, et al. 2023. “DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy”. Allergologie Select 7 (1): 229-235.

Pfaar, O., Hamelmann, E., Taube, C., Wagenmann, M., Wedi, B., Werfel, T., Bartel, D., Bonertz, A., Hartenstein, D., Kaul, S., et al. (2023). DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select 7, 229-235.

Pfaar, O., et al., 2023. DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select, 7(1), p 229-235.

O. Pfaar, et al., “DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy”, Allergologie Select, vol. 7, 2023, pp. 229-235.

Pfaar, O., Hamelmann, E., Taube, C., Wagenmann, M., Wedi, B., Werfel, T., Bartel, D., Bonertz, A., Hartenstein, D., Kaul, S., Mahler, V., Worm, M.: DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy. Allergologie Select. 7, 229-235 (2023).

Pfaar, Oliver, Hamelmann, Eckard, Taube, Christian, Wagenmann, Martin, Wedi, Bettina, Werfel, Thomas, Bartel, Detlef, Bonertz, Andreas, Hartenstein, Diana, Kaul, Susanne, Mahler, Vera, and Worm, Margitta. “DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy”. Allergologie Select 7.1 (2023): 229-235.

Daten bereitgestellt von European Bioinformatics Institute (EBI)